All Articles

I hope everyone has enjoyed their summer! We are now even closer to our 4th Annual AONN Conference in Memphis. I am hoping to see you there. We have a great lineup of experts to empower you with new knowledge and practical tools to make your navigation role better than ever—for you and for your patients!

This is part 3 of a 5-part series.

A review of the literature was done to evaluate the current evidence regarding the barriers that influence the transition of care in cancer survivorship and impact patient quality of life (QOL) and health outcomes.

I began my journey in oncology nursing more than 40 years ago and have never looked back.

I spent 8 long months in a city far from my own, undergoing intense chemotherapy and then an autologous stem cell transplant. Eventually, after a longer-than-I-would-have-liked stay in the hospital and another few weeks living close to the hospital in case of emergency, I was sent back home with a bagful of medicines and instructions on how/when/with what to take them.

I’ve never met MMA, but I can tell one very important thing about her from the blog she wrote about adherence to therapy at home.

Although it may be summer, which is known for being a time that employees take vacations, we all know that there is no vacation for our patients who have been diagnosed and are undergoing treatment for their cancer.

Continuing with our series of various unbranded offerings provided by pharmaceuticals and other companies that provide diagnostics and treatments for cancer patients, this list below comes from Merck.

Coordinating care; overcoming patient, provider, and health system barriers; and reducing delays across the care continuum have been long-standing challenges for healthcare managers.

Encompassing 420 counties in 13 states from southern New York to northern Mississippi, Appalachia is largely rural with a population characterized by a high poverty rate, a low educational level, a high rate of uninsurance or underinsurance, and limited access to healthcare. All pose substantial barriers to cancer screening, diagnosis, and treatment and are associated with increased cancer mortality.